logo

Tenax Therapeutics Inc (TENX)



Trade TENX now with
  Date
  Headline
1/19/2021 7:56:22 AM Tenax Therapeutics Announces Acquisition Of PH Precision Med
11/10/2020 8:36:06 AM Tenax Therapeutics Announces Presentation Of 24-Hour HELP Study Results At AHA Scientific Sessions 2020
8/17/2020 9:32:47 AM Tenax Therapeutics Q2 Net Loss $2.1 Mln Or $0.23/Shr Vs Loss $1.8 Mln Or $0.28/Shr Last Year
7/6/2020 9:03:11 PM Tenax Therapeutics Announces $8.0 Mln Registered Direct And PIPE Offerings
6/3/2020 8:32:18 AM Tenax Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
6/2/2020 7:35:37 AM Tenax Therapeutics Reports Positive Results From Phase 2 Trial Of Levosimendan In Patients With PH-HFpEF
4/9/2020 8:35:29 AM Tenax Therapeutics Announces Last Patient Completes Final Visit In Phase 2 HELP Study Of Levosimendan For PH-HFpEF
3/12/2020 8:33:05 AM Tenax Therapeutics Completes Enrollment In Phase 2 Pulmonary Hypertension Trial
3/12/2020 8:10:30 AM Tenax Therapeutics Announces $2.75 Mln Registered Direct Offering Priced At-the-Market
1/13/2020 8:40:37 AM Tenax Updates On Phase 2 Pulmonary Hypertension Clinical Trial; Expects Full Enrollment In Q1
10/31/2019 8:27:39 AM Tenax Therapeutics Provides Update On On-going Clinical Trial Of Levosimendan
3/11/2019 8:33:40 AM Tenax Enrolls First Patient For Phase 2 Pulmonary Hypertension Clinical Trial
12/11/2018 4:05:32 PM Tenax Therapeutics Closes $10 Mln Underwritten Offering